Importance

Loading Importance Indicators...

Abstract

The present invention provides a compound of the formula (I): ##STR00001## wherein A is selected from N, CH and CR, where R is selected from halogen, optionally substituted alkyl, aralkyl and aryl, OH, NH.sub.2, NHR.sup.1, NR.sup.1R.sup.2 and SR.sup.3, where R.sup.1, R.sup.2 and R.sup.3 are each optionally substituted alkyl, aralkyl or aryl groups; B is selected from OH, NH.sub.2, NHR.sup.4, H and halogen, where R.sup.4 is an optionally substituted alkyl, aralkyl or aryl group; D is selected from OH, NH.sub.2, NHR.sup.5, H, halogen and SCH.sub.3, where R.sup.5 is an optionally substituted alkyl, aralkyl or aryl group; X and Y are independendy selected from H, OH and halogen, with the proviso that when one of X and Y is hydroxy or halogen, the other is hydrogen; Z is OH, or, when X is hydroxy, Z is selected from hydrogen, halogen, hydroxy, SQ and OQ, where Q is an optionally substituted alkyl, aralkyl or aryl group; and W is OH or H, with the proviso that when W is OH, then A is CR where R is as defined above; or a tautomer thereof; or a pharmaceutically acceptable salt thereof; or an ester thereof. The invention also provides pharmaceutical compositions comprising compounds of formula (I), methods of preparing compounds of formula (I), and methods of treatment using compounds of formula (I).

Loading the Abstract Image...

First Claim